MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

ArriVent BioPharma, Inc. (AVBP)

ArriVent BioPharma, Inc. (AVBP)

|||

Balance Sheets Overview

Current Ratio
1415.65%
Quick Ratio
1415.65%
Cash Ratio
555.53%
Debt to Asset Ratio
7.06%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Right of use assets - operating ...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
154,682
62,103
45,540
112,672
Short-term investments
218,437
264,277
267,281
187,594
Prepaid expenses and other current assets
21,054
22,320
20,076
20,952
Total current assets
394,173
348,700
332,897
321,218
Long-term investments
-
-
-
5,108
Right of use assets - operating leases
370
370
13
49
Deferred offering costs
41
69
69
-
Other assets
134
156
190
180
Total assets
394,718
349,295
333,169
326,555
Accounts payable
2,217
8,727
5,934
5,933
Accrued expenses
25,309
16,169
19,997
15,569
Operating lease liabilities
318
99
14
56
Total current liabilities
27,844
24,995
25,945
21,558
Operating lease liabilities, net of current amount
33
320
-
-
Total liabilities
27,877
25,315
25,945
21,558
Common stock 0.0001 par value, 200,000,000 shares authorized 48,319,591 and 42,452,251 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
5
5
4
4
Additional paid-in capital
864,957
772,206
711,847
673,884
Accumulated deficit
-497,854
-447,961
-404,641
-369,097
Accumulated other comprehensive income (loss)
-267
-270
14
206
Total stockholders' equity
366,841
323,980
307,224
304,997
Total liabilities and stockholders' equity
394,718
349,295
333,169
326,555
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$218,437K (77.70%↑ Y/Y)Cash and cashequivalents$154,682K (37.17%↑ Y/Y)Prepaid expenses andother current assets$21,054K (45.58%↑ Y/Y)Total current assets$394,173K (57.58%↑ Y/Y)Right of use assets -operating leases$370K (335.29%↑ Y/Y)Other assets$134K (-72.03%↓ Y/Y)Deferred offering costs$41K Total assets$394,718K (46.46%↑ Y/Y)Total liabilities andstockholders' equity$394,718K (46.46%↑ Y/Y)Total stockholders'equity$366,841K (46.81%↑ Y/Y)Total liabilities$27,877K (41.97%↑ Y/Y)Accumulated deficit-$497,854K (-49.00%↓ Y/Y)Accumulated othercomprehensive income (loss)-$267K (-1383.33%↓ Y/Y)Additional paid-in capital$864,957K (48.11%↑ Y/Y)Total currentliabilities$27,844K (41.80%↑ Y/Y)Operating leaseliabilities, net of current...$33K Common stock 0.0001 parvalue, 200,000,000...$5K (25.00%↑ Y/Y)Accrued expenses$25,309K (63.52%↑ Y/Y)Accounts payable$2,217K (-45.39%↓ Y/Y)Operating leaseliabilities$318K (224.49%↑ Y/Y)